- Home
- WKC vs KNSA Comparison
WKC vs KNSA Comparison
Compare WKC & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKC
- KNSA
- Stock Information
- Founded
- WKC 1984
- KNSA 2015
- Country
- WKC United States
- KNSA United Kingdom
- Employees
- WKC N/A
- KNSA N/A
- Industry
- WKC Oil Refining/Marketing
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- WKC Energy
- KNSA Health Care
- Exchange
- WKC Nasdaq
- KNSA Nasdaq
- Market Cap
- WKC 1.6B
- KNSA 1.4B
- IPO Year
- WKC N/A
- KNSA 2018
- Fundamental
- Price
- WKC $30.75
- KNSA $20.02
- Analyst Decision
- WKC Hold
- KNSA Strong Buy
- Analyst Count
- WKC 5
- KNSA 5
- Target Price
- WKC $29.80
- KNSA $36.60
- AVG Volume (30 Days)
- WKC 629.3K
- KNSA 567.6K
- Earning Date
- WKC 02-20-2025
- KNSA 02-25-2025
- Dividend Yield
- WKC 2.21%
- KNSA N/A
- EPS Growth
- WKC 31.40
- KNSA N/A
- EPS
- WKC 1.13
- KNSA N/A
- Revenue
- WKC $42,168,000,000.00
- KNSA $384,098,000.00
- Revenue This Year
- WKC N/A
- KNSA $60.10
- Revenue Next Year
- WKC $5.70
- KNSA $34.22
- P/E Ratio
- WKC $27.19
- KNSA N/A
- Revenue Growth
- WKC N/A
- KNSA 54.41
- 52 Week Low
- WKC $21.38
- KNSA $16.56
- 52 Week High
- WKC $31.71
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- WKC 70.52
- KNSA 53.15
- Support Level
- WKC $26.98
- KNSA $19.31
- Resistance Level
- WKC $28.47
- KNSA $20.20
- Average True Range (ATR)
- WKC 0.65
- KNSA 0.80
- MACD
- WKC 0.09
- KNSA 0.06
- Stochastic Oscillator
- WKC 86.35
- KNSA 72.80
About WKC World Kinect Corporation
World Kinect Corp is a energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers . It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. Company operate in three reportable segments consisting of aviation, land, and marine. Company earn majority of revenue from Aviation segment.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.